Medical assessment
Thymosin Alpha-1
Advanced immune support for those who need extra resilience.
About
Thymomimetic peptide with restricted indication after immunological assessment and ruling out active malignancies. Subcutaneous administration.
Assessed indications
- ◆Documented mild immunodeficiency
- ◆Recovery after persistent viral infection
Contraindications
- ×Active autoimmune diseases
- ×Active oncological condition
- ×Pregnancy and lactation
- ×Transplant immunosuppression
Non-exhaustive list. Full assessment only in an in-person consultation.
Medical procedure
This protocol is a medical prescription. The indication, dose and eligibility are defined after clinical and lab assessment by Dr. Guilherme Klein (CRM-MG 69432). It cannot be purchased online without a prior consultation.
Request assessment